Remedios, Andelle Gain .

HRN: 07-17-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CO-AMOXICLAV 625MG (TAB)
05/03/2026
05/09/2026
PO
625
BID
Prom X 14 Hrs
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines